|
young TIL Clinical Trials
3 actively recruiting trials across 1 location
Pipeline
Phase 2: 3
Top Sponsors
- National Cancer Institute (NCI)3
Indications
- Cancer3
- Metastatic Endocrine Tumors/ Neuroendocrine Tumors1
- Adenosquamous Carcinoma1
- Squamous Cell Carcinoma1
- Advanced Non-Small Cell Lung Cancer1
Bethesda, Maryland3 trials
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
National Institutes of Health Clinical Center
Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
National Institutes of Health Clinical Center
Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
National Institutes of Health Clinical Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.